THE HAGUE, Netherlands, Nov. 27, 2025 /PRNewswire/ — On 12 December 2025, the Americas Youth Advocacy Team will be honored with the Youth Carnegie Peace Prize at the Peace Palace in The Hague. The organization is being recognized for its innovative approach to making peacebuilding accessible, connecting young peacebuilders across the Americas, and actively engaging… Continue reading Americas Youth Advocacy Team receives 2025 Youth Carnegie Peace Prize
Tag: People
Anyformat closes a €3.3 million seed round led by Kibo Ventures, with the aim of transforming document management for global corporations
MADRID, Nov. 27, 2025 /PRNewswire/ — Anyformat, a generative AI platform specialized in extracting and structuring complex data from any document, has raised a €3.3 million seed round led by Kibo Ventures, with follow-on participation from 4Founders, Abac Nest Ventures, and Decelera Ventures. All three funds also invested in the company’s previous round. The company… Continue reading Anyformat closes a €3.3 million seed round led by Kibo Ventures, with the aim of transforming document management for global corporations
Anyformat closes a €3.3 million seed round led by Kibo Ventures, with the aim of transforming document management for global corporations
MADRID, Nov. 27, 2025 /PRNewswire/ — Anyformat, a generative AI platform specialized in extracting and structuring complex data from any document, has raised a €3.3 million seed round led by Kibo Ventures, with follow-on participation from 4Founders, Abac Nest Ventures, and Decelera Ventures. All three funds also invested in the company’s previous round. The company… Continue reading Anyformat closes a €3.3 million seed round led by Kibo Ventures, with the aim of transforming document management for global corporations
IFS Cloud 25R2: Unlocking 10X Industrial Workforce Capacity with Digital Workers and Applied Industrial AI
Latest release demonstrates how IFS.ai continues to deliver contextual, embedded, industry-specific intelligence, and now agentic Digital Workers, to drive measurable outcomes, at speed, in the mission-critical industries that keep our world running. LONDON, Nov. 27, 2025 /PRNewswire/ — IFS, the leading provider of Industrial AI software, today announced the release of IFS Cloud 25R2, applying… Continue reading IFS Cloud 25R2: Unlocking 10X Industrial Workforce Capacity with Digital Workers and Applied Industrial AI
IFS Cloud 25R2: Unlocking 10X Industrial Workforce Capacity with Digital Workers and Applied Industrial AI
Latest release demonstrates how IFS.ai continues to deliver contextual, embedded, industry-specific intelligence, and now agentic Digital Workers, to drive measurable outcomes, at speed, in the mission-critical industries that keep our world running. LONDON, Nov. 27, 2025 /PRNewswire/ — IFS, the leading provider of Industrial AI software, today announced the release of IFS Cloud 25R2, applying… Continue reading IFS Cloud 25R2: Unlocking 10X Industrial Workforce Capacity with Digital Workers and Applied Industrial AI
German Manager Magazine: Ferrari, Europcar, Volkswagen, Porsche – the newsletter “manage:mobility”004563
Dear reader, The record of electric models with a retro look is mediocre. Volkswagen, for example, electrified its Bulli with a T1-like look under the name ID.Buzz – and made a mistake when looking at the sales figures. On the other hand, the electrically revitalized Renault R5 appears to be better received by customers. In… Continue reading German Manager Magazine: Ferrari, Europcar, Volkswagen, Porsche – the newsletter “manage:mobility”004563
L’Agence européenne des médicaments (EMA) accorde la désignation de médicament orphelin au traitement dérivé du plasma de Kedrion contre l’acéruloplasminémie congénitale, une maladie génétique rare du métabolisme du fer
Cette désignation marque une étape importante pour les patients et réaffirme l’engagement de Kedrion à répondre aux besoins médicaux non satisfaits dans le domaine des maladies rares et ultra-rares CASTELVECCHIO PASCOLI, Italie, 27 novembre 2025 /PRNewswire/ — Kedrion annonce que l’Agence européenne des médicaments (EMA) a accordé la désignation de médicament orphelin (ODD) à son traitement… Continue reading L’Agence européenne des médicaments (EMA) accorde la désignation de médicament orphelin au traitement dérivé du plasma de Kedrion contre l’acéruloplasminémie congénitale, une maladie génétique rare du métabolisme du fer
Introducing KuCoin Pay Travel: A Global Crypto Travel Platform Delivering Luxury Hotel Savings of Up to 60% Through a Partnership with Entravel
PROVIDENCIALES, Turks and Caicos Islands, Nov. 27, 2025 /PRNewswire/ — KuCoin Pay, the innovative cryptocurrency payment solution from KuCoin, has announced the launch of KuCoin Pay Travel, a new global crypto travel platform built in partnership with Entravel, the world’s leading AI-powered, crypto-native travel booking platform. Continue Reading Through this collaboration, KuCoin’s over 40 million users now gain access to more than… Continue reading Introducing KuCoin Pay Travel: A Global Crypto Travel Platform Delivering Luxury Hotel Savings of Up to 60% Through a Partnership with Entravel
Ctoph Exchange Launches Global Infrastructure Plan to Enhance Trading Speed and Stability
DALLAS, Nov. 27, 2025 /PRNewswire/ — Ctoph Exchange, a global digital asset trading platform, today announced a major expansion of its technology infrastructure alongside a significant upgrade to its proprietary trading system. As part of this initiative, the platform has established new regional data hubs across multiple international financial centers, strengthening execution efficiency, network resilience,… Continue reading Ctoph Exchange Launches Global Infrastructure Plan to Enhance Trading Speed and Stability
Neuraxpharm and mjn-neuro announce plans to launch EPISERAS®, a digital health solution using an AI-powered wearable device for the early detection of epileptic seizures
A non-invasive, AI-based, wearable earpiece that continuously monitors brain activity to enable the early detection of seizure risk in real time, alerting patients and caregivers minutes before an episode occurs1 This breakthrough innovation represents a major milestone in Neuraxpharm’s commitment to advancing both digital and personalised solutions that enhance safety and improve quality of life… Continue reading Neuraxpharm and mjn-neuro announce plans to launch EPISERAS®, a digital health solution using an AI-powered wearable device for the early detection of epileptic seizures